KEI Comments on Exclusive License to Stage One Immunotherapeutics
Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341
On October 20, 2025, Knowledge Ecology International (KEI) submitted comments to the NIH in response to the Federal Register notice titled, “Prospective Grant of an Exclusive Patent License: Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1A1 Inhibitors” (90 FR 47782) The…